Conference Coverage

Managing agitation in outpatient dementia


 

REPORTING FROM ACP INTERNAL MEDICINE


When considering augmentation, remember that “using benzodiazepines in the elderly is controversial, particularly with agitation in dementia. There is very little randomized clinical trial data on benzodiazepines in dementia. Actually, though, there are lots of clinical trials of benzodiazepines in dementia that feature benzodiazepines as rescue medication. So, clinically, there’s an awareness that the drugs work, but they haven’t been studied except as rescue medication,” he explained.

The phenomenon of paradoxical agitation occurring in elderly patients on benzodiazepines “is something to be careful about, but in fact it’s pretty uncommon. Just watch for it,” he added.

Dr. Luber is among many geriatric psychiatrists who preferentially turn to clonazepam (Klonopin) because its relatively long half-life allows for twice-daily administration.

“Think about using it regularly rather than PRN. You want to stay ahead of the agitation rather than behind it,” he advised.

Recommended Reading

Caffeine for apnea of prematurity found safe, effective at 11 years
Clinician Reviews
CDC: Marijuana use may spur industries to rethink current policies
Clinician Reviews
Suicide prevention, NRA team up for safer gun storage
Clinician Reviews
Self-harm
Clinician Reviews
Ketamine formulation study is ‘groundbreaking’
Clinician Reviews
Substance use linked to conversion to schizophrenia
Clinician Reviews
Up in Arms About Gun Violence
Clinician Reviews
Abstract: Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
Clinician Reviews
Commentary: Shifting the care delivery paradigm to diabetes-depression collaborative care models
Clinician Reviews
Emotional regulation training lowers risk of adolescents having sex
Clinician Reviews